Unternehmen HBM Healthcare Investments AG
Aktien
984345
CH0012627250
HBMN
Investitionsmanagement & Fondsbetreiber
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
206.5 CHF | +1.47% | +2.23% | +13.09% |
Kurzporträt
Mitarbeiterzahl: 700
Umsatz nach Geschäftsbereich
CHF in Millionen | 2023 | Gewichtung | 2024 | Gewichtung | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100,0
%
| -117 | 100,0 % | 3 | 100,0 % | -102.56% |
Umsatz je Region
CHF in Millionen | 2023 | Gewichtung | 2024 | Gewichtung | Delta |
---|---|---|---|---|---|
Switzerland
100,0
%
| -117 | 100,0 % | 3 | 100,0 % | -102.56% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Andreas Wicki
CEO | Chief Executive Officer | 64 | 01.07.01 |
Erwin Troxler
DFI | Director of Finance/CFO | 54 | 01.11.11 |
Benedikt Suter
SEC | Corporate Secretary | 60 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Chairman | 68 | 01.06.09 | |
Elaine Jones
BRD | Director/Board Member | 69 | 18.06.21 |
Mario Giuliani
BRD | Director/Board Member | 52 | 01.01.12 |
Rudolf Lanz
BRD | Director/Board Member | 73 | 01.01.03 |
Benedikt Suter
SEC | Corporate Secretary | 60 | - |
Stella Xu
BRD | Director/Board Member | 53 | 01.06.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 6 960 000 | 5 714 984 ( 82,11 %) | 92 270 ( 1,326 %) | 82,11 % |
Unternehmensbesitz
Name | Aktien | % | Bewertung |
---|---|---|---|
BENITEC BIOPHARMA INC. 8,98% | 841 395 | 8,98% | 5 839 281 $ |
2 910 | 0,04% | 591 423 $ |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Swixx Biopharma SA
Swixx Biopharma SA BiotechnologyHealth Technology Swixx Biopharma SA provides marketing and sales, regulatory, medical affairs, cold chain, logistic services to pharmaceutical companies. Its services also include receivables, collection, FX coverage, risk management, compliance, and reimbursement and market access. The company was founded by Petr Nemec and Robert Stuart Swanson in 2013 and is headquartered in Baar, Switzerland. |
Biotechnology
|
HBM Healthcare Investments (Cayman) Ltd.
HBM Healthcare Investments (Cayman) Ltd. Hospital/Nursing ManagementHealth Services Part of HBM Partners AG, HBM Healthcare Investments (Cayman) Ltd. provides healthcare services. The company is based in George Town, Cayman Islands. Andreas Wicki has been the CEO of the company since 2001. |
Hospital/Nursing Management
|
HBM Private Equity India
HBM Private Equity India Financial ConglomeratesFinance Part of HBM Partners AG, HBM Private Equity India is an Indian company that provides investment services. |
Financial Conglomerates
|
Sektor
Verlauf des Gewinns je Aktie
Jahresgewinne - Abweichungsrate
% 1. Jan. | Kap. | |
---|---|---|
+13.09% | 1.54 Mrd. | |
+17.22% | 3.1 Mrd. | |
+12.82% | 1.77 Mrd. | |
-11.54% | 1.21 Mrd. | |
+23.02% | 775 Mio. | |
+10.17% | 668 Mio. | |
+28.93% | 547 Mio. | |
-4.17% | 505 Mio. | |
+33.23% | 490 Mio. | |
+82.38% | 320 Mio. |
- Börse
- Aktien
- 984345 Aktie
- Unternehmen HBM Healthcare Investments AG